ES454181A1 - Procedimiento para preparar un analogo de prostaglandina. - Google Patents
Procedimiento para preparar un analogo de prostaglandina.Info
- Publication number
- ES454181A1 ES454181A1 ES454181A ES454181A ES454181A1 ES 454181 A1 ES454181 A1 ES 454181A1 ES 454181 A ES454181 A ES 454181A ES 454181 A ES454181 A ES 454181A ES 454181 A1 ES454181 A1 ES 454181A1
- Authority
- ES
- Spain
- Prior art keywords
- see formula
- carbon atoms
- hydrogen
- cis
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 7
- 229910052739 hydrogen Inorganic materials 0.000 abstract 6
- 239000001257 hydrogen Substances 0.000 abstract 6
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 4
- 239000002253 acid Substances 0.000 abstract 3
- 239000007795 chemical reaction product Substances 0.000 abstract 3
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000001153 fluoro group Chemical group F* 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000005907 ketalization reaction Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 150000003180 prostaglandins Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/42—Singly bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/41—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
- C07F3/02—Magnesium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
- C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64527675A | 1975-12-29 | 1975-12-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES454181A1 true ES454181A1 (es) | 1977-12-16 |
Family
ID=24588384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES454181A Expired ES454181A1 (es) | 1975-12-29 | 1976-12-13 | Procedimiento para preparar un analogo de prostaglandina. |
Country Status (18)
| Country | Link |
|---|---|
| US (4) | US4122282A (es) |
| JP (1) | JPS5283351A (es) |
| AU (1) | AU502349B2 (es) |
| BE (1) | BE849963A (es) |
| CA (1) | CA1077473A (es) |
| CH (1) | CH629747A5 (es) |
| DE (1) | DE2658207A1 (es) |
| ES (1) | ES454181A1 (es) |
| FR (1) | FR2336924A1 (es) |
| GB (2) | GB1554041A (es) |
| HU (1) | HU178365B (es) |
| IL (1) | IL50997A (es) |
| MX (1) | MX4940E (es) |
| NL (1) | NL7614389A (es) |
| PL (1) | PL116421B1 (es) |
| SE (1) | SE7614584L (es) |
| SU (1) | SU731895A3 (es) |
| ZA (1) | ZA767416B (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4048058A (en) * | 1975-08-13 | 1977-09-13 | Standard Oil Company (Indiana) | Methods to be used in reforming processes employing multi-metallic catalysts |
| US4267315A (en) * | 1979-05-01 | 1981-05-12 | The Upjohn Company | 2-Decarboxy-2-aminomethyl-11a-methano-TXA2 compounds |
| US4292445A (en) * | 1980-04-28 | 1981-09-29 | The Upjohn Company | Amide and sulfonamide derivatives of 2-decarboxy-2-aminomethyl-PG-type compounds |
| CA1241324A (en) | 1984-03-08 | 1988-08-30 | Paul A. Aristoff | Interphenylene carbacyclin derivatives |
| JPH0121948Y2 (es) * | 1985-03-29 | 1989-06-29 | ||
| US5270049A (en) * | 1990-11-09 | 1993-12-14 | Allergan, Inc. | 2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives |
| HU223068B1 (hu) * | 1995-12-20 | 2004-03-01 | Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. | Eljárás PGE1 prosztanoid előállítására |
| US7851504B2 (en) | 2005-03-16 | 2010-12-14 | Allergan, Inc. | Enhanced bimatoprost ophthalmic solution |
| US9241918B2 (en) | 2005-03-16 | 2016-01-26 | Allergan, Inc. | Enhanced bimatoprost ophthalmic solution |
| EP2454227B1 (en) | 2009-07-13 | 2020-08-19 | Patheon API Services Inc. | Synthesis of prostanoids |
| US9522153B2 (en) | 2009-12-22 | 2016-12-20 | Allergan, Inc. | Compositions and methods for lowering intraocular pressure |
| HUP1000284A3 (en) * | 2010-06-01 | 2012-08-28 | Avidin Kft | Use of derivatives of pgf1-alpha for preparation of medicament for reducing inflammation |
| CA2925927C (en) | 2013-09-30 | 2022-09-06 | George Petros Yiannikouros | Novel synthesis routes for prostaglandins and prostaglandin intermediates using metathesis |
| CN104860860B (zh) * | 2015-04-29 | 2017-09-19 | 东北制药集团股份有限公司 | 一种卡前列酯的纯化制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2166971A (en) * | 1932-09-14 | 1939-07-25 | Ig Farbenindustrie Ag | Production of amines |
| GB971700A (en) * | 1961-02-02 | 1964-09-30 | Boots Pure Drug Co Ltd | Anti-Inflammatory Agents |
| US3647804A (en) * | 1970-02-27 | 1972-03-07 | Upjohn Co | Cycloalkanecarboxamides |
| US3852296A (en) * | 1971-07-16 | 1974-12-03 | Richardson Merrell Spa | Mannich bases of cyclopentanones and cyclopent-2-enones and process of preparing the same |
| US3987087A (en) * | 1971-07-29 | 1976-10-19 | The Upjohn Company | Phenyl-substituted prostaglandin-f type analogs |
| US3954741A (en) * | 1972-06-07 | 1976-05-04 | Pfizer Inc. | N-substituted prostaglandin carboxamides |
| US3987085A (en) * | 1972-09-15 | 1976-10-19 | The Upjohn Company | 8β,11β,12α-PGF2.sub.α compounds |
-
1976
- 1976-08-30 US US05/719,056 patent/US4122282A/en not_active Expired - Lifetime
- 1976-08-30 US US05/719,054 patent/US4081478A/en not_active Expired - Lifetime
- 1976-08-30 US US05/719,055 patent/US4073808A/en not_active Expired - Lifetime
- 1976-08-30 US US05/719,053 patent/US4085139A/en not_active Expired - Lifetime
- 1976-11-16 CA CA265,797A patent/CA1077473A/en not_active Expired
- 1976-11-25 IL IL50997A patent/IL50997A/xx unknown
- 1976-12-09 AU AU20396/76A patent/AU502349B2/en not_active Expired
- 1976-12-13 ES ES454181A patent/ES454181A1/es not_active Expired
- 1976-12-13 ZA ZA767416A patent/ZA767416B/xx unknown
- 1976-12-15 CH CH1579476A patent/CH629747A5/de not_active IP Right Cessation
- 1976-12-21 HU HU76UO132A patent/HU178365B/hu unknown
- 1976-12-22 DE DE19762658207 patent/DE2658207A1/de not_active Withdrawn
- 1976-12-23 GB GB53739/76A patent/GB1554041A/en not_active Expired
- 1976-12-23 GB GB30065/78A patent/GB1554042A/en not_active Expired
- 1976-12-23 JP JP15439276A patent/JPS5283351A/ja active Granted
- 1976-12-24 NL NL7614389A patent/NL7614389A/xx not_active Application Discontinuation
- 1976-12-27 SE SE7614584A patent/SE7614584L/xx not_active Application Discontinuation
- 1976-12-28 SU SU762434653A patent/SU731895A3/ru active
- 1976-12-28 FR FR7639303A patent/FR2336924A1/fr active Granted
- 1976-12-29 BE BE173722A patent/BE849963A/xx not_active IP Right Cessation
- 1976-12-29 PL PL1976194803A patent/PL116421B1/pl unknown
-
1977
- 1977-01-03 MX MX775256U patent/MX4940E/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2336924A1 (fr) | 1977-07-29 |
| GB1554041A (en) | 1979-10-17 |
| US4085139A (en) | 1978-04-18 |
| NL7614389A (nl) | 1977-07-01 |
| HU178365B (en) | 1982-04-28 |
| FR2336924B1 (es) | 1984-08-17 |
| IL50997A0 (en) | 1977-01-31 |
| US4073808A (en) | 1978-02-14 |
| GB1554042A (en) | 1979-10-17 |
| SE7614584L (sv) | 1977-06-30 |
| PL116421B1 (en) | 1981-06-30 |
| BE849963A (fr) | 1977-06-29 |
| AU2039676A (en) | 1978-06-15 |
| DE2658207A1 (de) | 1977-07-07 |
| US4081478A (en) | 1978-03-28 |
| IL50997A (en) | 1982-05-31 |
| JPS5283351A (en) | 1977-07-12 |
| MX4940E (es) | 1983-01-10 |
| ZA767416B (en) | 1977-11-30 |
| US4122282A (en) | 1978-10-24 |
| CA1077473A (en) | 1980-05-13 |
| JPS5744666B2 (es) | 1982-09-22 |
| AU502349B2 (en) | 1979-07-19 |
| SU731895A3 (ru) | 1980-04-30 |
| CH629747A5 (de) | 1982-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES454181A1 (es) | Procedimiento para preparar un analogo de prostaglandina. | |
| IE42704L (en) | Prostaglandin derivatives and their preparation | |
| ES462061A1 (es) | Un procedimiento para la preparacion de nuevos derivados de tetrahidroisoquinoleina. | |
| ES388869A1 (es) | Un procedimiento para la preparacion de compuestos de del- ta3-cefalosporina. | |
| JPS51149247A (en) | Prostaglandin analogues, process for their preparation and drug compos itions containing them as effective ingredients | |
| ES390121A1 (es) | Un procedimiento para la preparacion de composiciones fun- gicidas. | |
| GB1448414A (en) | Prostaglandin intermediates | |
| DK156064C (da) | Analogifremgangsmaade til fremstilling af 2,4-(1h,3h)-quinazolindionderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| ES454086A1 (es) | Procedimiento para la preparacion de n-(r-tetrahidrofurfu- ril)-noroximorfona y n-(s-tetrahidrofurfuril)-norosimorfona nuevas. | |
| GB1506816A (en) | Prostaglandins | |
| IE42748L (en) | New prostanoic acid derivatives and process for their¹manufacture | |
| US4001306A (en) | Prostaglandin F.sub.α 15-monoacrylates | |
| ES421274A1 (es) | Procedimiento para la obtencion de derivados de acidos 12- epi-prostanoicos. | |
| ES455202A1 (es) | Un procedimiento para la preparacion de una (vinilo 2, 2- disustituido)-y-butirolactona. | |
| GB1449147A (en) | Prostaglandin intermediates method for electro coating metal surfaces with carbon | |
| PT82521A (de) | Verfahren zur herstellung von neuen phenolderivaten | |
| GB1439898A (en) | Method of preparing substituted cephalosporins and penicillins | |
| GB1529852A (en) | 8-azaprostaglandins and process for the preparation thereof | |
| ES390720A1 (es) | Procedimiento de preparacion de nuevos derivados de la ci- clopentanona. | |
| SE7511484L (sv) | Sett att framstella nitrofurylforeningar och anvendning derav som lekemedel | |
| ES337591A1 (es) | Procedimiento de obtencion de acidos acrilicos transusti- tuidos y sus sales, de efecto coleretico. | |
| SE7600729L (sv) | Prostaglandinforeningar | |
| GB1512272A (en) | Thiophene derivatives and process for their manufacture | |
| GB1460536A (en) | Process for 'he preparation of thiophene derivatives and deriva tives obtained by the said process | |
| GB1436832A (en) | Prostaglandin intermediates and their preparation |